Diagnomics Speeds Work to Analyze Human Genome Sequence
Researchers are deciphering genome sequences faster than ever, using Intel® Xeon® processors.
• Researchers needed faster analysis of genome sequences from next-generation sequencing data.
• Existing servers took days to complete a process.
• To apply to clinical settings, bioinformatics must be delivered in hours.
• Implemented HP ProLiant DL380* G8 Servers based on the Intel® Xeon® processor E5-2670
• Reduced indexing process from four days to 11 hours
• Exploration of how Intel data storage technologies may help launch new line of business
Unraveling DNA to personalize medicine
A decade ago, at the dawn of the revolution in human genomics, researchers studied the DNA of the typical human. Now, they’re focusing on the personal variations that can determine whether an individual has a higher risk for cancer or a genetic disease. Working with companies such as Illumina, which provides next-generation sequencing technologies, Diagnomics Inc. provides the analytical power to find variations in genes that can lead to clues about disease and personalized treatment.
“By knowing the variations in cancer tissue, we can understand what pathways have been broken during the disease development. That information can be used to tailor treatment and predict patient outcomes,” said Dr. Min Lee, the CEO, cofounder, and president of Diagnomics Inc. “This is a very hot field.”
Read the full Diagnomics Speeds Work to Analyze Human Genome Sequence Solution Brief.